Definium Therapeutics Us, Inc.
Clinical trials sponsored by Definium Therapeutics Us, Inc., explained in plain language.
-
New drug DT402 aims to ease social struggles in adults with autism
Symptom relief Recruiting nowThis study tests an experimental drug called DT402 in 20 adults with autism spectrum disorder. The goal is to see if it can reduce the severity of symptoms like trouble with socializing and communicating. Participants will take the drug and report how they feel using simple ratin…
Phase: PHASE2 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated May 26, 2026 05:58 UTC
-
New depression pill DT120 shows promise in phase 3 trial
Symptom relief Recruiting nowThis study tests an experimental oral medication called DT120 for adults with major depressive disorder. About 165 participants will receive either DT120 or a placebo for 12 weeks, followed by a 40-week period where everyone can take the drug. The main goal is to see if DT120 red…
Phase: PHASE3 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC